RMB/USD Fund

Assisted many well-known Chinese and foreign clients in forming over one thousand private investment funds of various types, including private equity investment funds, private venture capital investment funds, private securities investment funds, contractual private equity investment funds, corporate-form private equity funds, funds of funds (FOF), parallel funds, umbrella funds, QFLP funds, real estate funds, insurance funds, M&A funds, securities trader direct investment funds, secondary funds, etc., as well as offshore funds, including corporate- and partnership-form USD Funds and offshore FOFs, most notably for clients with roles as general partners of private equity funds, including but not limited to Qiming Venture Partners, Shunwei Capital, Northernlight Capital, Innovation Works, CICC Capital, AlphaX Partners, 6 Dimensions Capital, CBC Capital, Sinopharm Capital, 3E Bioventure, Yahui Medical Fund, In Capital, Gobi Partners, Vlight Capital,Soul Capital, Qingsong Fund, Koala Fund, China Reform Fund, etc., and those as limited partners of private equity funds include Yangtze River Industry Fund, Newerli Capital, GLP Capital, Shengjing 360, Kaiyuan Guochuang Capital, Yuanhe Capital, Suzhou Equity Investment Fund, China Culture FOF, Daxing FOF, E-Town Capital, Sino-US United MetLife Insurance Company Limited, Taikang Asset, Ping An Insurance Group, China Reinsurance Group, CAS Holdings, SDIC, Baidu, Tencent, JD.com, and Netease

VC/PE Investment

Provided legal services to many prominent private investment funds, listed companies, major industrial and other types of investment entities, including designing appropriate transaction structures, conducting legal due diligence, drafting transaction documents, issuing legal opinions and engaging in commercial negotiations in respect of their domestic and offshore equity investments, debt investments, and mezzanine investments for domestic and overseas venture capital project clients, including Sequoia Capital, IDG, Qiming Venture Partners, CBC Capital, Legend Capital, SAIF, Fidelity Capital, SIG Capital, Shunwei Funds, New Enterprise Capital, Genesis Capital, Shining Capital, Goldstone-investment, CAS Capital, Sinopharm Capital, In Capital, Yahui Precision Medical Fund, Northernlight Capital, AlphaX Partners, Koala Fund, NewQuest Capital, E-Town Capital, General Venture Capital, Tsing Capital, Gobi Partners, Vlight Capital, Panda Capital, CCB Capital, Sino-Ocean Capital, Value Capital, SDIC Gaoxin, SDIC Innovation, SDIC Venture Capital, CDB-CDC, Sunshine Insurance Group, BlueFocus, AK Group, Qingsong Fund, Legend Holdings, New World Strategic Investment, Shengjing, and  360

Corporate Financing, Reorganization, Mergers & Acquisitions (M&A), and General Corporate Matters

Represented clients in domestic and overseas equity VC, red chip structure construction/removal, employee option system design, listing structure construction, and restructuring & mergers & acquisitions (M&A), most notably for clients including but not limited to Lakala, Arrail Dental, SECOO, Hangzhou Sky-Mobi, Shanghai Touchpal, Longwill (quick care), Shouguang Vegetable Industry Holding Group, Immotors, Chinaso, Internet Based Engineering, Zhizhangyi, Hongyun Group, Cre8ive Group, Jiuyi Finance, Flymi, Lan-mi, SENSORO, OneAPM, Moseeker, ID5, RTMAP, Reach Surgical, Kidsmile, ETComm，Bondent, Werfen, VR Medical, GSTZY, YinYueTai, and HITBOT